Changes
!width="300"|Composition
!width="300"|Composition action
|-style="height:100px"
|US20060009430
BLOTECH (2004)
Beta-sitosterol reduce inflammation on scalp
|-style="height:100px"
|US20060009427
WARNER LAMBERT(2004)
|New class of 4-cycloalkoxy benzonitrile derivatives and salts
|Acts as androgen receptor modulators and blocks formation of DHT.
|-style="height:100px"
|US20050085467
WARNER LAMBERT(2004)
|New class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives.
|The compounds inhibit, or decrease, activation of androgen receptor by androgens.
|-style="height:100px"
|US20050118282
APHIOS Corp (2003)
|Supercritical fluid isolate of Saw Palmetto and Sperol (Serenoa repens berry) and their analogs or derivatives.
|Modulates androgenic activity by inhibiting 5.alpha.-reductase activity.
|-style="height:100px"
|US20060009429
Fundacion Pablo Cassara (2003)
|Pharmacologically active oligonucleotides (encompass both DNA and S-DNA bond)
|Oligonucleotides inhibit androgen receptor (AR) expression at very low concentrations in skin and hair follicle
|-style="height:100px"
|US20030007941
PFIZER INC (2001)
|Thyromimetic compounds (structurally similar to thyronine) with finasteride, or cyproterone acetate
|Activates thyroid hormone receptors in hair follicle which in turn promote elasticisation of follicle walls and hair follicle
|-style="height:100px"
|US20030073616
N/A (1995)
|Bradykinin antagonist (peptide of plasma origin from kininogen precursor-kallikrein)
|Inhibit synthesis of bradykinin receptors or compounds by binding to B2 receptor
|-style="height:100px"
|EP0279010
KAO Corp (1987)
